Quantcast The Daily Northwestern
College Media Network
  • Home

NU professor tests new colon cancer detecting technology

Vadim Backman receives a $7.5 million grant from National Cancer Institute

Clark, Libby

Issue date: 7/17/08 Section: Campus
  • Print
  • Email
Thanks to a recent $7.5 million grant from the National Cancer Institute, a Northwestern University professor will literally shine a light on colon cancer.

Over the next five years, McCormick School of Engineering Professor Vadim Backman will be conducting further research and clinical trials on an optical technology that he hopes will eventually be used in the medical mainstream as a routine colon pre-screen for patients.

The multi-faceted grant will be used to launch clinical trials at four different sites. The clinical core will be at Evanston Northwestern Healthcare, while other trials will be conducted at the University of Chicago, Indiana University and Stanford University. The grant will also fund further research on the actual scientific mechanisms at work.

In Backman's current trials, a simple fiber optic probe is inserted into the rectum. Light is scattered on the surrounding rectal tissue, and the resulting fingerprint is then analyzed. It is a minimally invasive procedure.

The optical technology is based on the biological phenomenon of the "field effect," which indicates that if a patient has a precancerous or cancerous lesion somewhere in the colon there are some very subtle changes that can be seen biologically throughout the entire organ, not just at the site of the polyp.

The advantage of Backman's technology is that it is very sensitive to small structures. Perturbations such as slight changes in blood supply or the microarchitecture of cells, otherwise invisible under a microscope, will be illuminated and observed.

Colorectal cancer is the second most common cause of death from cancer in the United States according to the NCI. "It's a shame people die from colon cancer because it's preventable," said Backman. "There are other cancers that are more difficult to find and treat."

Hemant K. Roy, M.D., who has worked closely with Backman and will be leading the clinical trials at his ENH site, hopes that the pre-screen will help better select the patients who need further examination. "We hope that this research will validate that a simple approach could be useful in detecting the risk of colon cancer and help target the percentage of the population that actually needs a colonoscopy," said Roy.
Page 1 of 2 next >

Article Tools

The DAILY encourages you to share your thoughts on this story. Please help us keep the discussion lively, but civil. Comments that are abusive to others, off-topic or vulgar, or comments that misrepresent someone's identity, will not be tolerated. We reserve the right to delete any comments in violation or to close comment threads on articles.

Please e-mail online@dailynorthwestern.com to flag a comment or for more information.

Be the first to comment on this story

  • NOTE: Email address will not be published

Type your comment below (html not allowed)

  I understand posting spam or other comments that are unrelated to this article will cause my comment to be flagged for deletion and possibly cause my IP address to be permanently banned from this server.

Advertisement

NU Football Insider



Cats Corner

Photobucket

Advertisement